Print

Print


and very sad that so many seem to be gone from this listserv. :(

trauti

On 2/1/2020 4:24 AM, Maryse Schild wrote:
> Glad you are still holding the fort, Rayilyn. It's been a long time
> maryse
>
> On Sat, 1 Feb 2020 at 08:00, Rayilyn Brown <[log in to unmask]> wrote:
>
>> Hi Maryse -           Ive wondered what has happened to everybody.
>> wish I    had good      news, Ray
>>
>> On 1/31/2020 2:40 AM, Maryse Schild wrote:
>>> Hi to you, Ray and Nic. ( and anyone still on this list). Good to have
>> some
>>> news.
>>>
>>> maryse
>>>
>>> On Fri, 31 Jan 2020 at 08:00, Rayilyn Brown <[log in to unmask]> wrote:
>>>
>>>> Hi Nic - my  24th has been my worst year yet/I dont pst much cause it
>>>> iw          so ohard to use the computer
>>>> -             see               what I mean?Amantadine        improved
>>>> my mmmobiliity but gave me hhhhhhhhhhhhhhorrible hallllucinations.  I
>>>> take Rimantadine which doesn't help           much            but Idont
>>>> have side effects,I also  take Rytary but cant wal
>>>> k                             but a step or two/worst problem ois
>>>> inbility to speak well eenooough to be             understood.
>>>>
>>>> Time sure   does fly               -       suddenly  at 84     Ima n
>>>> elder....was 60   when diagnosed/my computer guy has
>>>> parkinsonnnnnnnnnn's and he   is   55.  I  feel so ba d for him. He
>>>> has          bilateral tremprs     but can still funnction.
>>>>
>>>> good to  hear from you.Ray
>>>>
>>>> On 1/30/2020 6:43 AM, Nic Marais wrote:
>>>>> Hi Ray! How are you? Scary how time flies... In April this year it
>>>>> will be 26 years since iI was diagnosed at age 42.
>>>>> I still halucinate a lot, but I stick to my amantidine. It smooths the
>>>>> dyskineasias out, and improves my mobility.
>>>>> regards
>>>>>
>>>>> Nic 67/25
>>>>>
>>>>> On Thu, Jan 30, 2020, 09:00 Rayilyn Brown <[log in to unmask]
>>>>> <mailto:[log in to unmask]>> wrote:
>>>>>
>>>>>       -------- Forwarded Message --------
>>>>>       Subject:        Google Alert - Parkinson's Disease vaccine
>>>>>       Date:   Wed, 29 Jan 2020 20:01:51 -0800
>>>>>       From:   Google Alerts <[log in to unmask]
>>>>>       <mailto:[log in to unmask]>>
>>>>>       To: [log in to unmask] <mailto:[log in to unmask]>
>>>>>
>>>>>
>>>>>
>>>>>
>>>>>               Google
>>>>>       <
>> https://www.google.com/alerts?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ
>>>>>
>>>>>
>>>>>               Parkinson's Disease vaccine
>>>>>       Daily update ⋅ January 30, 2020
>>>>>
>>>>>
>>>>>               NEWS
>>>>>
>>>>>
>>>>>       FDA Response Bolsters Affiris' Plans for Potential *Parkinson's
>>>>>       Vaccine*
>>>>>       Affitope
>>>>>       <
>> https://www.google.com/url?rct=j&sa=t&url=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&ct=ga&cd=CAEYACoTOTEzMjY2MDQ1MDIxODU0NzIzNTIaZDQ1NzQ0OTU2MTY4OTQ5MDpjb206ZW46VVM&usg=AFQjCNGzyxpZrS304gRc-6nTbEPuMt3YZg
>>>>>
>>>>>       Parkinson's News Today
>>>>>       The U.S. Food *and* Drug Administration (FDA) has responded to
>>>>>       Affiris'
>>>>>       pre-investigational new drug (IND) submission regarding a planned
>>>>>       Phase
>>>>>       2 ...
>>>>>       Facebook
>>>>>       <
>> https://www.google.com/alerts/share?hl=en&gl=US&ru=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&ss=fb&rt=FDA+Response+Bolsters+Affiris%27+Plans+for+Potential+Parkinson%27s+Vaccine+Affitope&cd=KhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw&ssp=AMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw
>>>>>               Twitter
>>>>>       <
>> https://www.google.com/alerts/share?hl=en&gl=US&ru=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&ss=tw&rt=FDA+Response+Bolsters+Affiris%27+Plans+for+Potential+Parkinson%27s+Vaccine+Affitope&cd=KhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw&ssp=AMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw
>>>>>               Flag as irrelevant
>>>>>       <
>> https://www.google.com/alerts/feedback?ffu=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw
>>>>>
>>>>>
>>>>>
>>>>>       See more results
>>>>>       <
>> https://www.google.com/alerts?s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&start=1579665849&end=1580356911&source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ#history
>>>>>       | Edit this alert
>>>>>       <
>> https://www.google.com/alerts/edit?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&email=rayilynlee%40cox.net
>>>>>
>>>>>
>>>>>       You have received this email because you have subscribed to
>> *Google
>>>>>       Alerts*.
>>>>>       Unsubscribe
>>>>>       <
>> https://www.google.com/alerts/remove?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw
>>>>>       | View all your alerts
>>>>>       <
>> https://www.google.com/alerts?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ
>>>>>
>>>>>       RSS Receive this alert as RSS feed
>>>>>       <
>> https://www.google.com/alerts/feeds/04082120950631708698/17975067122935243170
>>>>>
>>>>>       Send Feedback
>>>>>       <
>> https://www.google.com/alerts?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&ffu=
>>>>>
>>>>>
>>>>>
>>>>>
>>>>    ----------------------------------------------------------------------
>>>>>       To sign-off Parkinsn send a message to:
>>>>>       mailto:[log in to unmask]
>>>>>       <mailto:[log in to unmask]>
>>>>>       In the body of the message put: signoff parkinsn
>>>>>
>>>> ----------------------------------------------------------------------
>>>> To sign-off Parkinsn send a message to: mailto:
>>>> [log in to unmask]
>>>> In the body of the message put: signoff parkinsn
>>>>
>>> ----------------------------------------------------------------------
>>> To sign-off Parkinsn send a message to: mailto:
>> [log in to unmask]
>>> In the body of the message put: signoff parkinsn
>> ----------------------------------------------------------------------
>> To sign-off Parkinsn send a message to: mailto:
>> [log in to unmask]
>> In the body of the message put: signoff parkinsn
>>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: mailto:[log in to unmask]
> In the body of the message put: signoff parkinsn

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn